Evidence map›Paper›PMID 41764676›Full record

ArticleEJNMMI radiopharmacy and chemistry2026

Long-term performance evaluation of a novel 3.26 GBq

Xiaoyang Hu, Renxin Hu, Yao Yang, Yuping Li, Yan Zhao, Ning Liu, Qiang Ge, Shuang Zhang, Songdong Ding

Abstract read
In one paragraph

Article in EJNMMI radiopharmacy and chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xiaoyang HuCollege of Chemistry, Sichuan University, Chengdu, 610064, China.
Renxin HuChengdu New Radiomedicine Technology Co., Ltd., Chengdu, China.
Yao YangChengdu New Radiomedicine Technology Co., Ltd., Chengdu, China.
Yuping LiChengdu New Radiomedicine Technology Co., Ltd., Chengdu, China.
Yan ZhaoDepartment of Nuclear Medicine, Affiliated Hospital of Southwest Medical University, Luzhou, China.
Ning LiuInstitute of Nuclear Science and Technology, Sichuan University, Chengdu, China.
Qiang GeChengdu New Radiomedicine Technology Co., Ltd., Chengdu, China.
Shuang ZhangChengdu New Radiomedicine Technology Co., Ltd., Chengdu, China. shuang.zhang@nrtmedtech.com.
Songdong DingCollege of Chemistry, Sichuan University, Chengdu, 610064, China. dsd68@163.com.

Funding

Nuclear Technology R&D Program HNKF202323(36)
6 · The paper itself

Abstract

background

resultsOver a two-year period, this generator maintained an average

conclusionThe enhancement of the

Indexed as

68Ge/68Ga generatorGallium-68Germanium-68Performance evaluationRadionuclide generator

Identifiers

PMID41764676
PMCPMC13057101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.